A well-designed approach can benefit clinical trials from protocol design to site support.
Raja Shankar
Advertisement
Vice President, Machine Learning, Research and Development Solutions, IQVIA
Articles by Raja Shankar
Advertisement
Latest Updated Articles
Leveraging AI/Machine Learning as an End-to-End DifferentiatorPublished: December 12th 2024 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
